Ben Gil Price, Director at Sarepta Therapeutics, Inc. (SRPT), bought 4,500 shares at $16.70 ($75K) on 2016-03-14, disclosed to the SEC on 2016-03-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| AVII | BUY | 2012-03-15 | $39K | — | Filing → |
| AVII | BUY | 2011-04-06 | $30K | — | Filing → |
| AVII | BUY | 2010-08-16 | $8K | — | Filing → |